Allogeneic Transplantation
Eligibility: Ages ≥ 18; Confirmed diagnosis of CLL or SLL; On active therapy and within 6 months of initiation on any first-line oral oncolytic therapy; Must be able to understand and voluntarily provide written informed consent
Eligibility: Age ≥ 18 years; Diagnosis of multiple myeloma, newly diagnosed or relapsed/refractory; Must be able to complete electronic or written quality of life surveys